Oviduct contractility in non-pregnant rats: changes in estrous cycle and effects of estrogen and progesterone antagonists
Reproduction · 2025
DOI: 10.1530/rep-25-0096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, 2025. Verfasst von Richa Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Engineering and Biomicrofluidics Laboratory, School of Biomedical Engineering, Indian Institute of Technology (Banaras Hindu University), Vara…. Hauptthemen laut MEDLINE: Estrous Cycle, Oviducts, Muscle Contraction, Estrogen Antagonists. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
In brief The oviduct plays a crucial role in natural conception, yet it has been largely overlooked in recent reproductive research compared to the uterus due to the increasing reliance on assisted reproductive technologies. This study offers a comprehensive characterization of oviduct contractility across the estrous cycle, correlates it with endogenous hormone levels, and reveals new insights into the role of the glucocorticoid receptor in regulating oviduct contractions, highlighting both receptor-mediated and non-receptor pathways in the regulation of tubal motility. Abstract This study aimed to systematically characterize oviduct contractility across the estrous cycle and to examine the regulatory roles of estradiol and progesterone using receptor antagonists and molecular docking to explore both receptor-mediated and ion channel pathways. Female Wistar rats ( n = 48) were used for this purpose. Oviducts were collected during proestrus, estrus, metestrus, and diestrus, and spontaneous contractions were recorded using an isometric force transducer. Serum levels of estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, and prolactin were measured through enzyme-linked immunosorbent assay (ELISA). To understand hormonal regulation, tamoxifen (10 mg/kg) was administered during proestrus, and mifepristone (5 mg/kg) was administered during metestrus. Immunofluorescence (IF) study was performed to evaluate expression of the estrogen, progesterone, and glucocorticoid receptors (ER, PR, and GR). Molecular docking analysis assessed interactions of the antagonists with estrogen and progesterone receptors and ion channels. Oviduct contractility was observed noticeably highest during proestrus (high estradiol) and lowest in metestrus and diestrus phases (high progesterone). Tamoxifen significantly reduced contraction parameters ( P < 0.001) and estradiol levels, while mifepristone notably increased contraction force ( P < 0.01), elevated estradiol levels ( P < 0.001), and decreased the proportion of progesterone hormone. The IF study indicated suppression of ER, PR, and GR expression following treatment with mifepristone. Docking analysis revealed that tamoxifen interacted with potassium channels and ERβ, while mifepristone showed high affinity for PR, GR, and calcium channels. These findings highlight that oviduct contractility is dynamically regulated across the estrous cycle through both receptor-mediated and potential non-receptor and non-genomic pathways involving ion channels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tissue Engineering and Biomicrofluidics Laboratory, School of Biomedical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, India.
- Department of Physiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
- Department of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, Uttar Pradesh, India.
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
- Department of Obstetrics and Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
ORCID-Profile: Sanjeev Kumar Mahto
Zitieren
APA
Singh, R., Sharma, P., Modanwal, S., Ranjan, H., Singh, A. K., Agarwal, S., & Mahto, S. K. (2025). Oviduct contractility in non-pregnant rats: changes in estrous cycle and effects of estrogen and progesterone antagonists. Reproduction. https://doi.org/10.1530/rep-25-0096
Vancouver
Singh R, Sharma P, Modanwal S, Ranjan H, Singh AK, Agarwal S, et al. Oviduct contractility in non-pregnant rats: changes in estrous cycle and effects of estrogen and progesterone antagonists. Reproduction. 2025. doi:10.1530/rep-25-0096
BibTeX
@article{Singh2025,
author = {Singh, Richa and Sharma, Parul and Modanwal, Shristi and Ranjan, Himanshu and Singh, Amaresh Kumar and Agarwal, Sakshi and Mahto, Sanjeev Kumar},
title = {Oviduct contractility in non-pregnant rats: changes in estrous cycle and effects of estrogen and progesterone antagonists},
journal = {Reproduction},
year = {2025},
doi = {10.1530/rep-25-0096}
}
EUVIMED